Insider Sale: Director at ATRC sold 5,313 Shares

GROVES REGINA E, a Director at AtriCure (NASDAQ: ATRC), sold 5,313 shares of the company on Sep 11, 2026 for an estimated $288,071. The move represents roughly 13.3% of their holdings in this class of stock. Following the transaction, their position stands at 34,546 shares of ATRC.

AtriCure Insider Trading Activity

Insiders at AtriCure have executed 12 trades in the open market over the last six months. All 12 were sales, with zero purchases recorded.

Here’s a breakdown of recent trading of ATRC stock by insiders over the last 6 months:

• WEHRWEIN SVEN sold 25,000 shares for an estimated $946,000.
• Privitera Salvatore (Chief Technical Officer) has made 0 purchases and 2 sales selling 11,420 shares for an estimated $608,692.
• Doraiswamy Vinayak (Chief Scientific Officer) has made 0 purchases and 3 sales selling 16,000 shares for an estimated $523,080.
• Dahlquist Karl S. (Chief Legal Officer) sold 9,370 shares for an estimated $458,099.
• GROVES REGINA E sold 5,313 shares for an estimated $288,071.
• Noznesky Justin J (Chief Mktg & Strategy Officer) sold 6,182 shares for an estimated $239,862.
• Prange Karen has made 0 purchases and 2 sales selling 6,564 shares for an estimated $224,233.
• Yuen Maggie sold 3,500 shares for an estimated $134,470.

AtriCure Revenue

AtriCure had revenues of $294.9M in H1 2026. This represents a 13.51% increase from the same period last year.